After Google Inc (GOOGL), Apple Inc. (AAPL) Is The Next To Collect DNA Samples To Further Genetic Disease Studies

Apple Inc. (NASDAQ:AAPL) is joining the growing list of companies and organizations interested in studying DNA. From Google Inc (NASDAQ:GOOGL) to the U.S. government, efforts are being made to gain more knowledge about diseases and genetics is part of the focus. Efforts are geared towards learning more about diseases with the hope of combating debilitating disorders like Parkinson’s disease.

Apple Inc. (NASDAQ:AAPL), in its efforts to facilitate better research on DNA, is about to begin its genetic databasing. What Apple wants to do is collect DNA from its various users through what has been described as a secure portal. The idea behind gathering DNA samples is part of Apple’s program that launched in March, known as the ResearchKit program. Those who volunteer their health information for the ResearchKit program will also benefit from being selected to participate in certain clinical studies.

Research partners

Apple already has plans for at least two studies with organizations that include Mount Sinai Hospital in New York and the University of California in San Francisco.

For DNA collection efforts, Apple Inc. (NASDAQ:AAPL) will provide users with kits on which they can apply saliva and return to laboratories approved by the company. The data will be stored in a cloud computing platform with some findings being made available on the user’s iPhone device.

Driving realization of a connected world

Apple Inc. (NASDAQ:AAPL) isn’t disclosing much about its genetic databasing plans. However, what is happening all around is that technology companies are bringing their various capabilities to accelerate the envisioned connected world. Under the so-called Internet of Things, or Internet of Everything in some quarters, about 50 billion devices are expected to be connected to the Internet by 2020. Such devices include anything from vehicles to goats in the field.

Apple Inc. (NASDAQ:AAPL) and Google are locked up in a race to build a genetic library to foster medical research. There is no doubt other prominent names in the technology world, like Microsoft Corporation (NASDAQ:MSFT) and Facebook Inc (NASDAQ:FB), might also show interest in health databasing.

Neha Gupta

Neha Gupta has been in the financial space for over six years now. Gupta earned her MBA degree from Symbiosis Centre of Distance Learning in 2009 and her passion for finance led her to pursue Chartered Financial Analyst (CFA) course. She has successfully completed Level II of her CFA. She is a veteran in article writing, which is depicted in her numerous pieces published on SeekingAlpha, Nextiphonenews, InsiderMonkey, MarketWatch, and Techinsider. Her crisp and eloquent writing finds its best place in Researchcows, where emphasis is given on developing rich content for various websites, products, business plans, trainings, and book writing.

You may also like...

Facebook Inc (FB) and Google (GOOGL) Eye Click-To-Call Market, A $4 Billion Opportunity

Facebook Inc (NASDAQ:FB) and Google Inc (NASDAQ:GOOG)(NASDAQ:GOOGL) are actively looking for new growth opportunities and one area they are training...